Plasma NT-proBNP increases in response to LPS administration in healthy men

Journal of Applied Physiology

Volumn 105, Issue 6, 2008, Pages 1741-1745

  Vila, Greisa ^a   Resl, Michael ^a   Stelzeneder, David ^a   Struck, Joachim ^b   Maier, Christina ^a   Riedl, Michaela ^a   Hülsmann, Martin ^a   Pacher, Richard ^a   Luger, Anton ^a   Clodi, Martin ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b THERMO FISHER SCIENTIFIC   (Germany)

Author keywords

B type natriuretic peptide; Bacterial endotoxin; C reactive protein; Human; Infection; Inflammation

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BACTERIUM LIPOPOLYSACCHARIDE; C REACTIVE PROTEIN; CARBOXY TERMINAL PRO ENDOTHELIN 1; ENDOTHELIN 1; MIDREGIONAL PROADRENOMEDULLIN; PROADRENOMEDULLIN; PROTEIN PRECURSOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BODY TEMPERATURE; CONTROLLED STUDY; DISEASE MODEL; ENDOTOXEMIA; HEART RATE; HUMAN; HUMAN EXPERIMENT; INFECTION; INFLAMMATION; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADRENOMEDULLIN; ADULT; BLOOD PRESSURE; C-REACTIVE PROTEIN; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; ENDOTHELIN-1; HUMANS; LIPOPOLYSACCHARIDES; MALE; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROTEIN PRECURSORS; YOUNG ADULT;

EID: 57349173068     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.90442.2008     Document Type: Article

References (36)

1. Balion CM, Santaguida P, McKelvie R, Hill SA, McQueen MJ, Worster A, Raina PS. Physiological, pathological, pharmacological, biochemical and hematological factors affecting BNP and NT-proBNP. Clin Biochem 41: 231-239, 2008.
2. Bibbins-Domingo K, Gupta R, Na B, Wu AHF, Schiller NB, Whoolly MD. N-terminal fragment of the prohormone BNP (NT-proBNP), cardiovascular events and mortality in patients with stable coronary heart disease. JAMA 297: 169-176, 2007.
3. Brueckmann M, Huhle G, Lang S, Haase KK, Bertsch T, Weiß C, Kaden JJ, Putensen C, Borggrefe N, Hoffmann U. Prognostic value of plasma N-terminal pro-brain natriuretic peptide in patients with severe sepsis. Circulation 112: 527-534, 2005.
4. Charpentier J, Luyt CE, Fulla Y, Vinsonneau C, Cariou A, Grabar S, Dhainaut JF, Mira JP, Chiche JD. Brain natriuretic peptide: a marker of myocardial dysfunction and prognosis during severe sepsis. Crit Care Med 32: 660-665, 2004.
5. Christ-Crain M, Morgenthaler NG, Struck J, Harbarth S, Bergmann A, Müller B. Mid-regional pro-adrenomedullin as a prognostic marker in sepsis: an observational study. Crit Care 9: 816-824, 2005.
6. Daniels LB, Maisel AS. Natriuretic peptides. J Am Coll Cardiol 50: 2357-2368, 2007.
7. Foote RS, Pearlman JD, Siegel AH, Yeo K-TJ. Detection of exercise-induced ischemia by changes in B-type natriuretic peptides. J Am Coll Cardiol 44: 1980-1987, 2004.
8. Grandel U, Grimminger F. Endothelial responses to bacterial toxins in sepsis. Crit Rev Immunol 23: 267-299, 2003.
9. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352: 1685-1695, 2005.
10. Heringlake M, Heide C, Bahlmann L, Eichler W, Pagel H, Schmucker P, Wergeland R, Armbruster FP, Klaus S. Effects of tilting and volume loading on plasma levels and urinary excretion of relaxin, NT-pro-ANP, and NT-pro-BNP in male volunteers. J Appl Physiol 97: 173-179, 2004.
11. Hinson JP, Kapas S. Adrenomedullin, a multifunctional regulatory peptide. Endocr Rev 21: 138-167, 2000.
12. Hirata Y, Mitaka C, Sato K, Nagura T, Tsunoda Y, Amaha K, Marumo F. Increased circulating adrenomedullin, a novel vasodilatory peptide, in sepsis. J Clin Endocrinol Metab 81: 1449-1453, 1996.
13. Kistorp C, Raymond I, Pederson F, Gustafsson F, Faber J, Hildebrandt P. N-terminal pro BNP, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults. JAMA 293: 1609-1616, 2005.
14. Lowry SF. Human endotoxemia: a model for mechanistic insight and therapeutic targeting. Shock 24, Suppl 1: 94-100, 2005.
15. Ma KK, Ogawa T, de Bold AJ. Selective upregulation of cardiac brain natriuretic peptide at the transcriptional and translational levels by pro-inflammatory cytokines and by conditioned medium derived from mixed lymphocyte reactions via p38 MAP kinase. J Mol Cell Cardiol 36: 505-513, 2004.
16. Maisel AS, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Duc P, Omland T, Storrow AB, Abraham WT, Wu AH, Clopton P, Steg PG, Westheim A, Knudsen CW, Perez A, Kazanegra R, Herrmann HC, McCullough PA. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 347: 161-167, 2002.
17. Morgenthaler NG, Struck J, Alonso C, Bergmann A. Measurement of midregional proadrenomedullin in plasma with an immunoluminometric assay. Clin Chem 51: 1823-1829, 2005.
18. Nikolaou NI, Goritsas C, Dede M, Paissios NP, Papavasileiou M, Rombola AT, Ferti A. Brain natriuretic peptide increases in septic patients without severe sepsis or shock. Eur J Intern Med 18: 535-541, 2007.
19. Omland T. Advances in congestive heart failure management in the intensive care unit: B-type natriuretic peptides in evaluation of acute heart failure. Crit Care Med 36: 17-27, 2008.
20. Papassotiriou J, Morgenthaler NG, Struck J, Alonso C, Bergmann A. Immunoluminometric assay for measurement of the C-terminal endothelin-1 precursor fragment in human plasma. Clin Chem 52: 1144-1151, 2006.
21. Richards M, Nicholls MG, Espiner EA, Lainchbury JG, Troughton RW, Elliott J, Frampton CM, Crozier IG, Yandle TG, Doughty R, MacMahon S, Sharpe N. Comparison of B-type natriuretic peptides for assessment of cardiac function and prognosis in stable ischemic heart disease. J Am Coll Cardiol 47: 52-60, 2006.
22. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 347: 1557-1565, 2002.
23. Ridker PM. High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 103: 813-1818, 2001.
24. Ruskoaho H. Cardiac hormones as diagnostic tools in heart failure. Endocr Rev 24: 341-356, 2003.
25. Schuetz P, Christ-Crain M, Morgenthaler NG, Struck J, Bergmann A, Müller B. Circulating precursor levels of endothelin-1 and adrenomedullin, two endothelium-derived, counteracting substances, in sepsis. Endothelium 14: 345-351, 2007.
26. Shor R, Rozenman Y, Bolshinsky A, Harpaz D, Tilis Y, Matas Z, Fux A, Boaz M, Halabe A. BNP in septic patients without systolic myocardial dysfunction. Eur J Intern Med 17: 536-540, 2006.
27. Smith SC Jr, Anderson J, Cannon RO 3rd, Fadl YY, Koenig W, Libby P, Lipshultz SE, Mensah GA, Ridker PM, Rosenson R, CDC, AHA. CDC/AHA workshop on markers of inflammation and cardiovascular disease: application to clinical and public health practice: report from the clinical practice discussion group. Circulation 110: 550-553, 2004.
28. Struck J, Tao C, Morgenthaler NG, Bergmann A. Identification of an adrenomedullin precursor fragment in plasma of sepsis patients. Peptides 25: 1369-1372, 2004.
29. Tang WH, Francis GS, Morrow DA, Newby LK, Cannon CP, Jesse RL, Storrow AB, Christenson RH, Apple FS, Ravkilde J, Wu AH. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical utilization of cardiac biomarker testing in heart failure. Circulation 116: 99-109, 2007.
30. Tomaru KiK, Arai M, Yokoyama T, Aihara Y, Sekiguchi KiK, Tanaka T, Nagai R, Kurabayashi M. Transcriptional activation of the BNP gene by lipopolysaccharide is mediated through GATA elements in neonatal rat cardiac myocytes. J Mol Cell Cardiol 34: 649-659, 2002.
31. Tschaikowsky K, Sagner S. Endothelin in septic patients: effects on cardiovascular and renal function and its relationship to proinflammatory cytokines. Crit Care Med 28: 1854-1860, 2000.
32. Ueda S, Nishio K, Akai Y, Fukushima H, Ueyama T, Kawai Y, Masui K, Yoshioka A, Okuchi K. Prognostic value of increased plasma levels of brain natriuretic peptide in patients with septic shock. Shock 26: 134-139, 2006.
33. Vila G, Maier C, Riedl M, Nowotny P, Ludvik B, Luger A, Clodi M. Bacterial endotoxin induces biphasic changes in plasma ghrelin in healthy humans. J Clin Endocrinol Metab 92: 3930-3934, 2007.
34. Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Omland T, Wolf PA, Vasan RS. Plasma natriuretic peptide levels and the risk of cardiovascular events and mortality. N Engl J Med 350: 655-663, 2004.
35. Webster JI, Tonelli L, Sternberg EM. Neuroendocrine regulation of immunity. Annu Rev Immunol 20: 125-163, 2002.
36. Williams SG, Ng LL, O'Brien RJ, Taylor S, Wright DJ, Tan LB. Is plasma N-BNP a good indicator of the functional reserve of failing hearts? The FRESH-BNP study. Eur J Heart Fail 6: 891-900, 2004.